Skip to content

Replimune Group REPL Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$5.05M-26.8%
Immunome logo
ImmunomeIMNM
$2.83M-32.1%
CG Oncology logo
CG OncologyCGON
$4.51M+337%
Erasca, Inc. logo
Erasca, Inc.ERAS
$28.27M-10.3%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$38.59M-23.0%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$22.61M-7.4%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+30.2%
Enterprise value$885.15M+30.0%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's operating lease ROU assets?
Replimune Group (REPL) reported operating lease ROU assets of $3.5M in Q4 2025.
How has Replimune Group's operating lease ROU assets changed year-over-year?
Replimune Group's operating lease ROU assets decreased by 15.1% year-over-year, from $4.12M to $3.5M.
What is the long-term trend for Replimune Group's operating lease ROU assets?
Over 4 years (2021 to 2025), Replimune Group's operating lease ROU assets has grown at a -8.7% compound annual growth rate (CAGR), from $5.75M to $4M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.